Literature DB >> 33500526

Clonal hematopoiesis in adult pure red cell aplasia.

Naohito Fujishima1, Junki Kohmaru2, Souichi Koyota2, Keiji Kuba2,3, Tomoo Saga4, Ayumi Omokawa4, Yuki Moritoki4, Shigeharu Ueki4, Fumihiro Ishida5, Shinji Nakao6, Akira Matsuda7, Akiko Ohta8, Kaoru Tohyama9, Hiroshi Yamasaki10, Kensuke Usuki11, Yasuhiro Nakashima12, Shinya Sato13, Yasushi Miyazaki13, Yasuhito Nannya14, Seishi Ogawa14, Kenichi Sawada15, Kinuko Mitani16, Makoto Hirokawa17.   

Abstract

Idiopathic pure red cell aplasia (PRCA) and secondary PRCA associated with thymoma and large granular lymphocyte leukemia are generally considered to be immune-mediated. The PRCA2004/2006 study showed that poor responses to immunosuppression and anemia relapse were associated with death. PRCA may represent the prodrome to MDS. Thus, clonal hematopoiesis may be responsible for treatment failure. We investigated gene mutations in myeloid neoplasm-associated genes in acquired PRCA. We identified 21 mutations affecting amino acid sequences in 11 of the 38 adult PRCA patients (28.9%) using stringent filtering of the error-prone sequences and SNPs. Four PRCA patients showed 7 driver mutations in TET2, DNMT3A and KDM6A, and 2 PRCA patients carried multiple mutations in TET2. Five PRCA patients had mutations with high VAFs exceeding 0.3. These results suggest that clonal hematopoiesis by stem/progenitor cells might be related to the pathophysiology of chronic PRCA in certain adult patients.

Entities:  

Year:  2021        PMID: 33500526      PMCID: PMC7838416          DOI: 10.1038/s41598-021-81890-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  37 in total

1.  Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion.

Authors:  Sa A Wang; Gang Yue; Lloyd Hutchinson; Marie L Landry; Robert P Hasserjian; Suyang Hao; Naomi Galili; Azra Raza; Bruce A Woda
Journal:  Br J Haematol       Date:  2007-06-03       Impact factor: 6.998

2.  Myelodysplastic syndrome with erythroid hypoplasia.

Authors:  R Goyal; N Varma; R K Marwaha
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

3.  Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

Authors:  Tetsuichi Yoshizato; Yasuhito Nannya; Yoshiko Atsuta; Yusuke Shiozawa; Yuka Iijima-Yamashita; Kenichi Yoshida; Yuichi Shiraishi; Hiromichi Suzuki; Yasunobu Nagata; Yusuke Sato; Nobuyuki Kakiuchi; Keitaro Matsuo; Makoto Onizuka; Keisuke Kataoka; Kenichi Chiba; Hiroko Tanaka; Hiroo Ueno; Masahiro M Nakagawa; Bartlomiej Przychodzen; Claudia Haferlach; Wolfgang Kern; Kosuke Aoki; Hidehiro Itonaga; Yoshinobu Kanda; Mikkael A Sekeres; Jaroslaw P Maciejewski; Torsten Haferlach; Yasushi Miyazaki; Keizo Horibe; Masashi Sanada; Satoru Miyano; Hideki Makishima; Seishi Ogawa
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

4.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

5.  Red cell aplasia in myelodysplastic syndrome.

Authors:  P J Williamson; D G Oscier; A J Bell; T J Hamblin
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

6.  Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia.

Authors:  Toru Kawakami; Nodoka Sekiguchi; Jun Kobayashi; Tatsuya Imi; Kazuyuki Matsuda; Taku Yamane; Sayaka Nishina; Yasushi Senoo; Hitoshi Sakai; Toshiro Ito; Tomonobu Koizumi; Makoto Hirokawa; Shinji Nakao; Hideyuki Nakazawa; Fumihiro Ishida
Journal:  Blood Adv       Date:  2018-10-23

7.  Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.

Authors:  Jean-Jacques Kiladjian; Géraldine Visentin; Emilie Viey; Sylvie Chevret; Virginie Eclache; Jerome Stirnemann; Jean Henri Bourhis; Salem Chouaib; Pierre Fenaux; Anne Caignard
Journal:  Haematologica       Date:  2008-02-11       Impact factor: 9.941

Review 8.  Chronic immune response dysregulation in MDS pathogenesis.

Authors:  Laura Barreyro; Timothy M Chlon; Daniel T Starczynowski
Journal:  Blood       Date:  2018-08-13       Impact factor: 22.113

9.  STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.

Authors:  Fumihiro Ishida; Kazuyuki Matsuda; Nodoka Sekiguchi; Hideki Makishima; Chiaki Taira; Kayoko Momose; Sayaka Nishina; Noriko Senoo; Hitoshi Sakai; Toshiro Ito; Yok-Lam Kwong
Journal:  Cancer Sci       Date:  2014-01-22       Impact factor: 6.716

Review 10.  Acquired pure red cell aplasia: updated review of treatment.

Authors:  Kenichi Sawada; Naohito Fujishima; Makoto Hirokawa
Journal:  Br J Haematol       Date:  2008-05-28       Impact factor: 6.998

View more
  2 in total

1.  DNA Methyl Transferase 3A (DNMT3A) Mutation Presenting as Isolated Pure Red Cell Aplasia.

Authors:  Adarsh Sidda; Gurusidda Manu; Mohamed Alsharedi; Jennifer Dotson; Niru Nahar
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 2.  The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies.

Authors:  Hans Felix Staehle; Heike Luise Pahl; Jonas Samuel Jutzi
Journal:  Biomolecules       Date:  2021-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.